Inogen | INGN - Assets


Inogen reported $307.01M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 456.82M 13.42M Sep/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 884.8M 27.13M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 19.85B 209M Mar/2026
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 44.35B 678M Mar/2026
Chart Industries USD 9.81B 16.6M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.63B 293.4M Mar/2026
Edwards Lifesciences USD 13.7B 425M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Orthofix International USD 886.6M 35.95M Mar/2026
Philips EUR 26.94B 605M Dec/2025
ResMed USD 8.78B 280.91M Mar/2026
Steris USD 10.59B 180.7M Dec/2025
Stryker USD 46.29B 1.55B Mar/2026
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
X T L Biopharmaceuticals USD 714K 7.84M Jun/2025
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026